Literature DB >> 17846856

Salvage surgery after failed chemoradiation for anal canal cancer: should the paradigm be changed for high-risk tumors?

David Stewart1, Yan Yan, Ira J Kodner, Elisa Birnbaum, James Fleshman, Robert Myerson, David Dietz.   

Abstract

It is common belief that patients failing chemoradiation therapy (CRT) for squamous cell cancer of the anus (SCCA) can be salvaged with subsequent surgery. The aim of this study was to examine our experience with abdominoperineal resection (APR) in cases of persistent or recurrent SCCA with an emphasis on survival and morbidity. All patients between 1985 and 2001 undergoing salvage APR were reviewed. Details of CRT, surgery, tumor characteristics, postoperative complications, and survival were obtained from medical records. There were 22 patients (13 women, 9 men) with a mean age of 62 years (range=42-87). Initial tumors were AJCC stage 2 (16 cases), 3A (3 cases), and 4 (1 case). Mean radiation dose was 47.6 Gy (30-60) and most received concomitant 5-FU. In 20 patients, APR was felt to be "curative" but only 13 (65%) had negative margins on final pathology. Thirteen (59%) perineal wounds broke down with a median time to healing of 7 months. Tumor differentiation (p=0.02) and positive resection margins (p=0.004) were significantly associated with DFS (5-year DFS of 37%). Salvage APR in patients with poorly differentiated tumors or positive resection margins has a high morbidity and poor survival and may warrant a planned APR after CRT instead.

Entities:  

Mesh:

Year:  2007        PMID: 17846856     DOI: 10.1007/s11605-007-0232-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  12 in total

1.  Results of abdominoperineal resections for failures after combination chemotherapy and radiation therapy for anal canal cancers.

Authors:  R S Zelnick; P A Haas; M Ajlouni; E Szilagyi; T A Fox
Journal:  Dis Colon Rectum       Date:  1992-06       Impact factor: 4.585

2.  Combined therapy for cancer of the anal canal: a preliminary report.

Authors:  N D Nigro; V K Vaitkevicius; B Considine
Journal:  Dis Colon Rectum       Date:  1974 May-Jun       Impact factor: 4.585

3.  Depth of invasion, location, and size of cancer of the anus dictate operative treatment.

Authors:  W H Schraut; C H Wang; P J Dawson; G E Block
Journal:  Cancer       Date:  1983-04-01       Impact factor: 6.860

4.  Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome.

Authors:  R J Myerson; F Kong; E H Birnbaum; J W Fleshman; I J Kodner; J Picus; G A Ratkin; T E Read; B J Walz
Journal:  Radiother Oncol       Date:  2001-10       Impact factor: 6.280

5.  Carcinoma of the anal canal. A clinical and pathologic study of 188 cases.

Authors:  B M Boman; C G Moertel; M J O'Connell; M Scott; L H Weiland; R W Beart; L L Gunderson; R J Spencer
Journal:  Cancer       Date:  1984-07-01       Impact factor: 6.860

6.  Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy.

Authors:  W E Longo; A M Vernava; T P Wade; M A Coplin; K S Virgo; F E Johnson
Journal:  Ann Surg       Date:  1994-07       Impact factor: 12.969

7.  Salvage abdominoperineal resection following combined chemotherapy and radiotherapy for epidermoid carcinoma of the anus.

Authors:  J D Ellenhorn; W E Enker; S H Quan
Journal:  Ann Surg Oncol       Date:  1994-03       Impact factor: 5.344

8.  Salvage abdominoperineal resection in anal epidermoid cancer.

Authors:  P J Nilsson; C Svensson; S Goldman; B Glimelius
Journal:  Br J Surg       Date:  2002-11       Impact factor: 6.939

9.  Carcinoma of the anal canal: a study of 79 cases.

Authors:  B G Dougherty; H L Evans
Journal:  Am J Clin Pathol       Date:  1985-02       Impact factor: 2.493

10.  Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy.

Authors:  Robert P Akbari; Philip B Paty; Jose G Guillem; Martin R Weiser; Larissa K Temple; Bruce D Minsky; Leonard Saltz; W Douglas Wong
Journal:  Dis Colon Rectum       Date:  2004-05-28       Impact factor: 4.585

View more
  7 in total

1.  Neoplasms of anal canal and perianal skin.

Authors:  Daniel Leonard; David Beddy; Eric J Dozois
Journal:  Clin Colon Rectal Surg       Date:  2011-03

Review 2.  Current understanding and potential immunotherapy for HIV-associated squamous cell carcinoma of the anus (SCCA).

Authors:  Christian Marin-Muller; Min Li; Changyi Chen; Qizhi Yao
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

Review 3.  New approach to anal cancer: individualized therapy based on sentinel lymph node biopsy.

Authors:  Paola De Nardi; Michele Carvello; Carlo Staudacher
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

Review 4.  Diagnosis and management of anal cancer.

Authors:  Pascal Gervaz; Nicolas Buchs; Philippe Morel
Journal:  Curr Gastroenterol Rep       Date:  2008-10

5.  Outcomes of abdominoperineal resection for management of anal cancer in HIV-positive patients: a national case review.

Authors:  Ira L Leeds; Hasan Alturki; Joseph K Canner; Eric B Schneider; Jonathan E Efron; Elizabeth C Wick; Susan L Gearhart; Bashar Safar; Sandy H Fang
Journal:  World J Surg Oncol       Date:  2016-08-05       Impact factor: 2.754

Review 6.  Survival and Operative Outcomes After Salvage Surgery for Recurrent or Persistent Anal Cancer.

Authors:  In Ja Park; George Chang
Journal:  Ann Coloproctol       Date:  2020-12-31

7.  Salvage Abdominoperineal Resection for Squamous Cell Anal Cancer: A 30-Year Single-Institution Experience.

Authors:  J A W Hagemans; S E Blinde; J J Nuyttens; W G Morshuis; M A M Mureau; J Rothbarth; C Verhoef; J W A Burger
Journal:  Ann Surg Oncol       Date:  2018-04-24       Impact factor: 5.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.